HOXD13 and diffuse large B-cell lymphoma: In patients with DLBCL, elevated pretherapeutic sPD-1 levels were associated with worst prognostic indicators such as age (≥60), disseminated clinical stage, performance status (ECOG ≥2), elevated levels of plasma LDH, and presence of ≥1 extranodal site (90).